Novavax, Inc. (NVAX) is near the top in its industry group according to InvestorsObserver. NVAX gets an overall rating of 63. That means it scores higher than 63 percent of stocks. Novavax, Inc. gets a 76 rank in the Biotechnology industry. Biotechnology is number 24 out of 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Novavax, Inc. (NVAX) stock has gained 21.61% while the S&P 500 has fallen -2.35% as of 9:44 AM on Friday, Feb 28. NVAX has gained $2.55 from the previous closing price of $11.80 on volume of 1,278,132 shares. Over the past year the S&P 500 is higher by 4.47% while NVAX has gained 1.77%. NVAX lost -$7.12 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Read the rest here:
Is Novavax, Inc. (NVAX) Stock Near the Top or Bottom of the Biotechnology Industry? - InvestorsObserver